IGC Pharma Inc

IGC11 Dec 2024
Healthcare
$0.37
+0.02 (+2.20%)
Lowest Today
$0.37
Highest Today
$0.38
Today’s Open
$0.37
Prev. Close
$0.36
52 Week High
$0.91
52 Week Low
$0.25
To Invest in IGC Pharma Inc

IGC Pharma Inc

Healthcare
IGC11 Dec 2024
+0.02 (+2.20%)
1M
3M
6M
1Y
5Y
Low
$0.37
Day’s Range
High
$0.38
0.37
52 Week Low
$0.25
52-Week Range
52 Week High
$0.91
0.25
1 Day
-
1 Week
+5.04%
1 month return
-2.12%
3 month return
-1.13%
6 month return
-17.2%
1 Year return
+28.01%
3 Years return
-68.12%
5 Years return
-44.42%
10 Years return
-

Market Status

Fundamentals
Market Cap
28.19 mln
PB Ratio
3.88
PE Ratio
0
Enterprise Value
27.34 mln
Total Assets
9.9 mln
Volume

Company Financials

Fund house & investment objective

Company Information
IGC Pharma, Inc., a clinical stage pharmaceutical company, engages in developing treatments for Alzheimer's disease. The company's lead product is IGC-AD1, which is in a Phase 2B clinical trial as a treatment for agitation in dementia due to Alzheimer's; and TGR-63, IGC-1C, IGC-M3, and LMP in pre-clinical development. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. The company was incorporated in 2005 and is headquartered in Potomac, Maryland.
Organisation
IGC Pharma Inc
Employees
67
Industry
Biotechnology
CEO
Mr. Ram  Mukunda
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step

Click here to see your activities